Monday, October 06, 2014 2:57:37 PM
On October 2, 2014, International Isotopes Inc. (the “Company”) entered into an Isotope and Technical Service Order Form with the U.S. Department of Energy (the “DOE”) for the irradiation of cobalt targets for the production of cobalt-60 (the “Agreement”). Pursuant to the Agreement, the Company will receive cobalt irradiation services in certain target positions at the DOE’s Advanced Test Reactor at the Idaho National Laboratory (the “ATR”) for the next 10 years at a fixed price for all cobalt material from the ATR, with an annual 5% escalation in price.
The term of the Agreement begins on October 1, 2014 and ends on September 30, 2024. The Company may terminate the Agreement at any time upon 180 days’ advanced written notice to the DOE. The DOE may terminate the Agreement upon failure of the Company to pay amounts due under the Agreement, if the Company no longer is licensed to receive cobalt-60, or if the DOE determines that termination of the Agreement is necessary for the national defense, security or environmental safety of the United States.
The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by the terms of the Agreement. The Company will file a copy of the Agreement as an exhibit to its Annual Report on Form 10-K for the fiscal year ending December 31, 2014.
Recent INIS News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:05:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:35:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 08:21:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 08:19:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:02:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/07/2023 11:47:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 07:50:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 07:58:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2023 07:39:51 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM